Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diseases of the Thyroid

Free Subscription Articles published in PLoS One Retrieve available abstracts of 69 articles: HTML format

Single Articles

January 2025
1. GRIMMICHOVA T, Verespejova L, Urbaniova Z, Chovanec M, et al
   Acquired hypothyroidism, iodine status and hearing impairment in adults: A pilot study.
   PLoS One. 2025;20:e0305787.
   PubMed     Abstract available
   
   
   
2. QIU Z, Yu S, Zheng L, Lou Y, et al
   Global burden of thyroid cancer in adolescents and young adults (aged 15-39 years) from 1990 to 2021: A systematic analysis of the Global Burden of Disease Study 2021.
   PLoS One. 2025;20:e0318605.
   PubMed     Abstract available
   
   
   
3. KONG F, Han B, Wu Z, Chen J, et al
   Explore the possible influence of Sjogren's syndrome on thyroid cancer: A literature data mining and meta-analysis.
   PLoS One. 2025;20:e0318747.
   PubMed     Abstract available
   
   
   
4. KIM J, Park KA, Han K, Jung JH, et al
   Ocular motor cranial neuropathy and risk of thyroid cancer: A Korean population-based study.
   PLoS One. 2025;20:e0319872.
   PubMed     Abstract available
   
   
   
5. LIU Y, Kong X, Sun Q, Cui T, et al
   Identification and validation of the common pathogenesis and hub biomarkers in Papillary thyroid carcinoma complicated by rheumatoid arthritis.
   PLoS One. 2025;20:e0317369.
   PubMed     Abstract available
   
   
   
6. HE S, Nie H, Yin X, Zhong Z, et al
   Identification of key extracellular proteins as the potential biomarkers in thyroid eye disease.
   PLoS One. 2025;20:e0322415.
   PubMed     Abstract available
   
   
   
7. COLLI SL, Boycho ME, Papendieck P, Mangone FM, et al
   Prevalent genetic alterations in pediatric thyroid carcinoma: Insights from an Argentinean study.
   PLoS One. 2025;20:e0323271.
   PubMed     Abstract available
   
   
   
8. LUO Y, Ye Y, Saibaidoula Y, Zhang Y, et al
   Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma.
   PLoS One. 2025;20:e0323013.
   PubMed     Abstract available
   
   
   
9. TEKETELEW BB, Berta DM, Chane E, Mekuanint A, et al
   Diagnostic accuracy of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in differentiating thyroid tumors: A systematic review and meta-analysis.
   PLoS One. 2025;20:e0322382.
   PubMed     Abstract available
   
   
   
10. MANDEFRO B, Kelem A, Gebreegziabher ZA, Gelaw Y, et al
    Hematological abnormalities and associated factors among patients with thyroid hormone dysfunction at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
    PLoS One. 2025;20:e0322748.
    PubMed     Abstract available
    
    
    
11. KESIBI D, Rotondi M, Edgell H, Tamim H, et al
    Associations between age at natural menopause and risk of hypothyroidism among postmenopausal women from the Canadian Longitudinal Study on Aging (CLSA).
    PLoS One. 2025;20:e0324635.
    PubMed     Abstract available
    
    
    
12. XU C, Wang Z, Zhou J, Hu F, et al
    Application research of artificial intelligence software in the analysis of thyroid nodule ultrasound image characteristics.
    PLoS One. 2025;20:e0323343.
    PubMed     Abstract available
    
    
    
13. ZHANG J, Yue K, Wu Y, Jing C, et al
    Multi-omics analysis and single-cell sequencing revealed the lysosome associated molecular subtypes and prognostic model development of papillary thyroid carcinoma.
    PLoS One. 2025;20:e0325486.
    PubMed     Abstract available
    
    
    
14. WILSON JB, Hoang TD, Lee ML, Epstein M, et al
    Reverse T3 in patients with hypothyroidism on different thyroid hormone replacement.
    PLoS One. 2025;20:e0325046.
    PubMed     Abstract available
    
    
    
15. KUMAR A, Dhanka S, Sharma A, Sharma A, et al
    Comprehensive framework for thyroid disorder diagnosis: Integrating advanced feature selection, genetic algorithms, and machine learning for enhanced accuracy and other performance matrices.
    PLoS One. 2025;20:e0325900.
    PubMed     Abstract available
    
    
    
16. REN H, Wang M, Sun X, Yuan Y, et al
    The safety and feasibility of transoral thyroidectomy vestibular approach in the treatment of thyroid disorders: An overview of systematic reviews.
    PLoS One. 2025;20:e0326318.
    PubMed     Abstract available
    
    
    
17. LI C, Li Q, Shi X, Han S, et al
    Papillary thyroid microcarcinoma and papillary thyroid carcinoma: Clinical characteristics and stratification of treatment strategies.
    PLoS One. 2025;20:e0327423.
    PubMed     Abstract available
    
    
    
18. BAILEY WJ, Smits BMG, Erdos Z, Gaspar JM, et al
    LINE-1 transposition into murine Thyroglobulin results in congenital thyroid dysplasia.
    PLoS One. 2025;20:e0325493.
    PubMed     Abstract available
    
    
    
19. OUYANG H, Dou X, Li X, Cao M, et al
    Sex disparities in papillary thyroid cancer survival: Divergent patterns of relative and absolute effects across the age spectrum.
    PLoS One. 2025;20:e0328876.
    PubMed     Abstract available
    
    
    
20. MOPOSITA MOLINA FD, Agnes G, Zandona MR, Izquierdo R, et al
    Prevalence and diagnostic reliability of BRAF, RAS mutations, and RET/PTC rearrangements in a Latin American public health service population with thyroid nodular disease.
    PLoS One. 2025;20:e0329407.
    PubMed     Abstract available
    
    
    
21. LARSEN KD, Hvilsom GB, Andersen TV, Homoe P, et al
    Spinal needles versus conventional needles for fine-needle aspiration biopsy of thyroid nodules-A multicenter randomized controlled trial.
    PLoS One. 2025;20:e0321043.
    PubMed     Abstract available
    
    
    
22. LI Y, Li H, Sun Q, Long Q, et al
    A disproportionality analysis of FDA adverse event reporting system (FAERS) events for methimazole and propylthiouracil.
    PLoS One. 2025;20:e0328889.
    PubMed     Abstract available
    
    
    
23. SHU T, Wu X, Wei C, Chen C, et al
    ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway.
    PLoS One. 2025;20:e0328881.
    PubMed     Abstract available
    
    
    
24. CHUKIR T, Yaghmour M, Almutairi T, Chagoury O, et al
    Weight and body composition outcomes with liraglutide in individuals with well-treated hypothyroidism: A retrospective case-control study.
    PLoS One. 2025;20:e0332091.
    PubMed     Abstract available
    
    
    
25. LI F, Chen W, Chen Z, Lian B, et al
    Genotype-phenotype correlations of germline mutations in exon 10 of the RET proto-oncogene from 14 MEN2A families of Ethnic Han Chinese.
    PLoS One. 2025;20:e0332136.
    PubMed     Abstract available
    
    
    
26. BEGUM MN, Sarker SK, Islam MT, Bhuyan GS, et al
    Altered carnitine-acylcarnitine profiles in levothyroxine-treated congenital hypothyroid patients with fatigue: An LC-MS/MS-based study from Bangladesh.
    PLoS One. 2025;20:e0331474.
    PubMed     Abstract available
    
    
    January 2024
27. JI S
    SSC: The novel self-stack ensemble model for thyroid disease prediction.
    PLoS One. 2024;19:e0295501.
    PubMed     Abstract available
    
    
    
28. SINGH H, Shahid MZ, Harrison SL, Lane DA, et al
    Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0296413.
    PubMed     Abstract available
    
    
    
29. CHIU WC, Wu ZF, Lee MS, Chen JY, et al
    Propofol-based total intravenous anesthesia is associated with less postoperative recurrence than desflurane anesthesia in thyroid cancer surgery.
    PLoS One. 2024;19:e0296169.
    PubMed     Abstract available
    
    
    
30. KUO CY, Tsai CH, Wu JK, Cheng SP, et al
    Sublethal thermal stress promotes migration and invasion of thyroid cancer cells.
    PLoS One. 2024;19:e0298903.
    PubMed     Abstract available
    
    
    
31. AN R, Gu YX, Ni XH, Lei Y, et al
    The feasibility and clinical significance of lateral approach thyroidectomy.
    PLoS One. 2024;19:e0300604.
    PubMed     Abstract available
    
    
    
32. JIN X, Yin Z, Li X, Guo H, et al
    TIM3 activates the ERK1/2 pathway to promote invasion and migration of thyroid tumors.
    PLoS One. 2024;19:e0297695.
    PubMed     Abstract available
    
    
    
33. BEGUM MN, Mahtarin R, Islam MT, Antora NJ, et al
    High-resolution melt curve analysis: An approach for variant detection in the TPO gene of congenital hypothyroid patients in Bangladesh.
    PLoS One. 2024;19:e0293570.
    PubMed     Abstract available
    
    
    
34. XIE L, He L, Zhang W, Wang H, et al
    Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells.
    PLoS One. 2024;19:e0298631.
    PubMed     Abstract available
    
    
    
35. ZHANG X, Yu J, Zhu J, Wei H, et al
    A meta-analysis of unilateral axillary approach for robotic surgery compared with open surgery for differentiated thyroid carcinoma.
    PLoS One. 2024;19:e0298153.
    PubMed     Abstract available
    
    
    
36. BAUER BS, Azcoaga-Lorenzo A, Agrawal U, Fagbamigbe AF, et al
    Subclinical hypothyroidism in Wales from 2000 to 2021: A descriptive cohort study based on electronic health records.
    PLoS One. 2024;19:e0298871.
    PubMed     Abstract available
    
    
    
37. JEONG C, Baek H, Bae J, Hwang N, et al
    Gut microbiome in the Graves' disease: Comparison before and after anti-thyroid drug treatment.
    PLoS One. 2024;19:e0300678.
    PubMed     Abstract available
    
    
    
38. AKTER S, Mustafa HA
    Analysis and interpretability of machine learning models to classify thyroid disease.
    PLoS One. 2024;19:e0300670.
    PubMed     Abstract available
    
    
    
39. BECHTOLD MA, Lin Y, Miller ML, Prieto JM, et al
    Serum metabolome analysis in hyperthyroid cats before and after radioactive iodine therapy.
    PLoS One. 2024;19:e0305271.
    PubMed     Abstract available
    
    
    
40. PLEIC N, Babic Leko M, Gunjaca I, Zemunik T, et al
    Vitamin D and thyroid function: A mendelian randomization study.
    PLoS One. 2024;19:e0304253.
    PubMed     Abstract available
    
    
    
41. CARMONA-HIDALGO B, Martin-Gomez C, Herrera-Ramos E, Rodriguez-Lopez R, et al
    Systematic review of thyroid function in NKX2-1-related disorders: Screening and diagnosis.
    PLoS One. 2024;19:e0303880.
    PubMed     Abstract available
    
    
    
42. YAMADA K, Tanabe A, Hashimoto M, Ohsugi M, et al
    A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis.
    PLoS One. 2024;19:e0308076.
    PubMed     Abstract available
    
    
    
43. SONG L, Li B, Wu H, Wu C, et al
    Understanding the factors of wearable devices among the patients with thyroid cancer: A modified UTAUT2 model.
    PLoS One. 2024;19:e0305944.
    PubMed     Abstract available
    
    
    
44. GOTTLICH M, Chatterjee K, Moran C, Heldmann M, et al
    Altered brain functional connectivity in patients with resistance to thyroid hormone ss.
    PLoS One. 2024;19:e0306538.
    PubMed     Abstract available
    
    
    
45. SOARES AA, Nagashima YG, Alves CX, de Medeiros KS, et al
    Zinc and thyroid cancer: A systematic review and meta-analysis protocol.
    PLoS One. 2024;19:e0307617.
    PubMed     Abstract available
    
    
    
46. ALFURAIH AM, Alotaibi AM, Alshammari AK, Alrashied BF, et al
    Evaluating diagnostic accuracy and agreement of TI-RADS scoring in thyroid nodules: A comparative analysis between sonographers and radiologists.
    PLoS One. 2024;19:e0312121.
    PubMed     Abstract available
    
    
    
47. CARMONA-HIDALGO B, Herrera-Ramos E, Rodriguez-Lopez R, Nou-Fontanet L, et al
    Systematic review of thyroid function in NKX2-1-related disorders: Treatment and follow-up.
    PLoS One. 2024;19:e0309064.
    PubMed     Abstract available
    
    
    
48. ABBAS MA, Munir K, Raza A, Amjad M, et al
    A novel meta learning based stacked approach for diagnosis of thyroid syndrome.
    PLoS One. 2024;19:e0312313.
    PubMed     Abstract available
    
    
    
49. LEE JY, Lee SB, Yang SW, Paik JS, et al
    Linsitinib inhibits IGF-1-induced cell proliferation and hyaluronic acid secretion by suppressing PI3K/Akt and ERK pathway in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
    PLoS One. 2024;19:e0311093.
    PubMed     Abstract available
    
    
    
50. DEE W, Alaaeldin Ibrahim R, Marouli E
    Histopathological domain adaptation with generative adversarial networks: Bridging the domain gap between thyroid cancer histopathology datasets.
    PLoS One. 2024;19:e0310417.
    PubMed     Abstract available
    
    
    January 2023
51. RZESZUTEK M, Pieta M, Van Hoy A, Zawistowska M, et al
    Coping profiles, depression, and body image anxiety during the Covid-19 pandemic: Comparative analysis of females with thyroid diseases and a non-clinical sample.
    PLoS One. 2023;18:e0282302.
    PubMed     Abstract available
    
    
    
52. ALESSANDRO S, Paradiso E, Lazzaretti C, Sperduti S, et al
    Intracellular cGMP increase is not involved in thyroid cancer cell death.
    PLoS One. 2023;18:e0283888.
    PubMed     Abstract available
    
    
    
53. YANG F, Zhang J, Zhao Z, Liu Y, et al
    Artemisinin suppresses aerobic glycolysis in thyroid cancer cells by downregulating HIF-1a, which is increased by the XIST/miR-93/HIF-1a pathway.
    PLoS One. 2023;18:e0284242.
    PubMed     Abstract available
    
    
    
54. LEE SH, Lee S, Lee J, Lee JK, et al
    Effective encoder-decoder neural network for segmentation of orbital tissue in computed tomography images of Graves' orbitopathy patients.
    PLoS One. 2023;18:e0285488.
    PubMed     Abstract available
    
    
    
55. LIU Y, Li Q, Xu Y, Chen Y, et al
    Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0286097.
    PubMed     Abstract available
    
    
    
56. STANIC G, Marinkovic S, Milin Lazovic J, Ignjatovic Ristic D, et al
    Association between affective temperaments and psychosomatic symptoms in women with Hashimoto's thyroiditis.
    PLoS One. 2023;18:e0290066.
    PubMed     Abstract available
    
    
    
57. BEGUM MN, Mahtarin R, Islam MT, Ahmed S, et al
    Molecular investigation of TSHR gene in Bangladeshi congenital hypothyroid patients.
    PLoS One. 2023;18:e0282553.
    PubMed     Abstract available
    
    
    
58. BEGUM MN, Mahtarin R, Ahmed S, Shahriar I, et al
    Investigation of the impact of nonsynonymous mutations on thyroid peroxidase dimer.
    PLoS One. 2023;18:e0291386.
    PubMed     Abstract available
    
    
    
59. DHABHAI N, Chowdhury R, Virmani A, Chaudhary R, et al
    Burden, risk factors and outcomes associated with adequately treated hypothyroidism in a population-based cohort of pregnant women from North India.
    PLoS One. 2023;18:e0282381.
    PubMed     Abstract available
    
    
    
60. SHANG F, Liu X, Ren X, Li Y, et al
    Competing-risks model for predicting the prognostic value of lymph nodes in medullary thyroid carcinoma.
    PLoS One. 2023;18:e0292488.
    PubMed     Abstract available
    
    
    
61. SISCART J, Perejon D, Serna MC, Oros M, et al
    Prevalence, risk factors, and consequences of hypothyroidism among pregnant women in the health region of Lleida: A cohort study.
    PLoS One. 2023;18:e0278426.
    PubMed     Abstract available
    
    
    
62. HOSSEINIYAN KHATIBI SM, Zununi Vahed S, Homaei Rad H, Emdadi M, et al
    Uncovering key molecular mechanisms in the early and late-stage of papillary thyroid carcinoma using association rule mining algorithm.
    PLoS One. 2023;18:e0293335.
    PubMed     Abstract available
    
    
    
63. KANANKULAM VELLIANGIRI S, Ballal S, Prasad Yadhav M, Tripathi M, et al
    A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
    PLoS One. 2023;18:e0294343.
    PubMed     Abstract available
    
    
    
64. HEO J, Lee S, Park J, Yang H, et al
    Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
    PLoS One. 2023;18:e0294145.
    PubMed     Abstract available
    
    
    
65. CHENG CW, Fang WF, Lin JD
    Associations of serum keratin 1 with thyroid function and immunity in Graves' disease.
    PLoS One. 2023;18:e0289345.
    PubMed     Abstract available
    
    
    
66. SONG WJ, Um IC, Kwon SR, Lee JH, et al
    Predictive factors of lymph node metastasis in papillary thyroid cancer.
    PLoS One. 2023;18:e0294594.
    PubMed     Abstract available
    
    
    
67. TATEAI Y, Kawakami K, Teramae M, Fukuda N, et al
    Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma.
    PLoS One. 2023;18:e0294320.
    PubMed     Abstract available
    
    
    January 2021
68. FAN R, Dong L, Li P, Wang X, et al
    Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma.
    PLoS One. 2021;16:e0251962.
    PubMed     Abstract available
    
    
    
69. LIU Y, Geng H, Liu X, Cao M, et al
    A meta-analysis of circulating microRNAs in the diagnosis of papillary thyroid carcinoma.
    PLoS One. 2021;16:e0251676.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.